Showing results (81-90 of 414) with videos related to

Sort By:
Pageof 42
Annals of Hematology|May 6, 2004
Genetic classification of acute myeloid leukemia (AML)T Haferlach, S Schnittger, W Kern, et al.
Journal of Chromatography|December 29, 1989
Detection and separation of intracellular 1-beta-D-arabinofuranosylcytosine-5-triphosphate by ion-pair high-performance liquid chromatographyE Schleyer, G Ehninger, M Zühlsdorf, et al.
Annals of Hematology|December 22, 1999
Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cellsJ Braess, J Pförtner, W Kern, et al.
Leukemia Research|January 1, 1990
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trialW Hiddemann, M Zühlsdorf, B Wörmann, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocolT Bösing, A Roessner, W Hiddemann, et al.
Blut|August 1, 1990
Treatment of refractory multiple myeloma with the vincristine-adriamycin-dexamethasone (VAD) regimenW Stenzinger, A Blömker, W Hiddemann, et al.
British Journal of Haematology|August 6, 2000
Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterationsL Maeck, D Haase, C Schoch, et al.
British Journal of Haematology|December 21, 2000
Differential cellular expression of the human MSH2 protein in normal and myelodysplastic haematopoiesisL Maeck, P Kohaus, D Haase, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|November 1, 1995
[Pharmacokinetics of buprenorphine in subcutaneous administration]I Gralow, W F von Hornstein, E Schleyer, et al.
Hematological Oncology|July 1, 1989
Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: results of a clinical phase I/II studyW Hiddemann, D Urbanitz, P Preusser, et al.
Pageof 42